Biotinylated Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (MALS verified) | S1N-M13L3-200ug

(No reviews yet) Write a Review
SKU:
716-S1N-M13L3-200ug
Availability:
IN STOCK
Weight:
1.00 KGS
€1,948.00
Frequently bought together:

Description

Biotinylated Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (MALS verified) | S1N-M13L3-200ug| Gentaur Distribution US, UK & Europe

It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Source: Biotinylated AntiN/ASARSN/ACoVN/A2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARSN/ACoVN/A2 S1 protein. This chimeric antibody is purified by Protein A affinity chromatography.

Molecule: Spike RBD.

Species: Mouse.

Tag: Human IgG1 | Human Kappa.

Conjugate: Biotin-labeled.

Purity: 95%.

Charactirization: PBS, pH7.4.

Storage Conditions: -20℃.

Shipping Conditions: RT

View AllClose

Additional Information

Size:
200 ug
View AllClose